Brind.

SAM is involved in the FDA regulating pharmaceutical cannabinoid therapeutics development.

1 report, 1 independent Updated Jun 18

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

SAM FDA

Keep exploring

The entities involved

SAM
Nothing else this week.
FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Related events

MMJ International Holdings is pursuing FDA-approved cannabinoid medicines.Jul 14
Agencies (FDA and DEA) implement a regulatory shift concerning cannabis.Sat 02:48

Coverage

Newest first; wire copies grouped

Jun 18mondaq.com